Abstract
Hemangioblastomas are highly vascular tumors that are typically benign and slow-growing, corresponding to WHO grade I.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Suggested Reading
Barresi V, Vitarelli E, Branca V, Antonelli M, Giangaspero F, Barresi G. Expression of brachyury in hemangioblastoma: potential use in differential diagnosis. Am J Surg Pathol. 2012;36:1052–7.
Carney E, Banerjee P, Ellis C, Albadine R, Sharma E, Chaux A, et al. PAX2(−)/PAX8(−)/Inhibin A(+) immunoprofile in hemangioblastoma: a helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system. Am J Surg Pathol. 2011;35:262–7.
Chaudhry AP, Montes M, Cohn GA. Ultrastructure of cerebellar hemangioblastoma. Cancer. 1978;42:1834–50.
Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery. 2001;48:55–62.
Glasker S. Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features. Fam Cancer. 2005;4:37–42.
Jagannathan J, Lonser RR, Smith R, DeVroom HL, Oldfield EH. Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg. 2008;108:210–22.
Koh ES, Nichol A, Millar BA, Menard C, Pond G, Laperriere NJ. Role of fractionated external beam radiotherapy in hemangioblastoma of the central nervous system. Int J Radiat Oncol Biol Phys. 2007;69:1521–6.
Lach B, Gregor A, Rippstein P, Omulecka A. Angiogenic histogenesis of stromal cells in hemangioblastoma: ultrastructural and immunohistochemical study. Ultrastruct Pathol. 1999;23:299–310.
Lallu S, Naran S, Palmer D, Bethwaite P. Cyst fluid cytology of cerebellar hemangioblastoma: a case report. Diagn Cytopathol. 2008;36:341–3.
Lemeta S, Jarmalaite S, Pylkkanen L, Bohling T, Husgafvel-Pursiainen K. Preferential loss of the nonimprinted allele of ZAC1 tumor suppressor gene in human capillary hemangioblastoma. J Neuropathol Exp Neurol. 2007;66:860–7.
Rodesch G, Gaillard S, Loiseau H, Brotchi J. Embolization of intradural vascular spinal cord tumors: report of five cases and review of the literature. Neuroradiology. 2008;50:145–51.
Roy S, Chu A, Trojanowski JQ, Zhang PJ. D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas. Acta Neuropathol (Berl). 2005;109:497–502.
Weinbreck N, Marie B, Bressenot A, Montagne K, Joud A, Baumann C, et al. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: Utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining. Am J Surg Pathol. 2008;32:1051–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing AG
About this chapter
Cite this chapter
Richard, H.T., Fuller, C.E. (2016). Hemangioblastoma. In: Adesina, A., Tihan, T., Fuller, C., Poussaint, T. (eds) Atlas of Pediatric Brain Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-33432-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-33432-5_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33430-1
Online ISBN: 978-3-319-33432-5
eBook Packages: MedicineMedicine (R0)